Associations between Cryptococcus Genotypes, Phenotypes, and Clinical Parameters of Human Disease: A Review

Marhiah C Montoya1,2, Paul M Magwene3, John R Perfect1,2

  • 1Division of Infectious Diseases, Department of Medicine, Duke University, Durham, NC 27710, USA.

Insights

Cryptococcus neoformans and Cryptococcus gattii cause opportunistic infections. This review examines fungal genotypes and phenotypes linked to cryptococcosis severity and patient outcomes.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Human Pathogens

Background:

  • The genus Cryptococcus includes two major opportunistic human fungal pathogens: C. neoformans and C. gattii.
  • Cryptococcosis, a fungal infection, commonly affects the lungs or central nervous system.
  • Current understanding of Cryptococcus pathogenesis largely relies on in vitro and animal models, which do not fully replicate the human host environment.

Purpose of the Study:

  • To investigate the genetic and phenotypic variations within Cryptococcus species.
  • To understand how these variations influence disease initiation and progression in humans.
  • To identify human and fungal factors contributing to cryptococcal pathogenesis and adverse clinical outcomes.

Main Methods:

  • Review of current scientific literature on Cryptococcus infections.
  • Analysis of clinical presentations and health outcomes associated with Cryptococcus strains.
  • Correlation of pathogenicity and virulence with specific fungal genotypes and phenotypes.

Main Results:

  • Summary of diverse clinical manifestations of cryptococcosis.
  • Discussion of varying disease severity based on host-pathogen interactions.
  • Identification of links between specific Cryptococcus genotypes/phenotypes and clinical outcomes.

Conclusions:

  • Understanding Cryptococcus genotype-phenotype-clinical outcome relationships is crucial for managing cryptococcosis.
  • Further research is needed to bridge the gap between experimental models and human infection dynamics.
  • Identifying specific risk factors can improve patient prognosis and therapeutic strategies.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.2K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
234
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
530